# HCA — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-09-09. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 6.2 · Fundamentals 6.5 · Technicals 4.5 · Growth 5.5 · Risk 6.8

## Summary

HCA is a cash-generative, scale-advantaged hospital operator now trading at ~13x trailing / 12.5x forward earnings after a ~28% drawdown from the $556 52-week high, reflecting a 2026 guidance cut tied to payer-mix deterioration post-ACA subsidy expiration. The setup is a value/mean-reversion candidate near $400 support with a $453 sell-side target, but structural leverage ($51.6B debt, negative equity of -$6.6B) and an active securities-fraud probe cap conviction ahead of the Oct 23 print.

## Price targets (12-month horizon)

- Bear: $365.00
- Base: $435.00
- Bull: $490.00

## News context

The dominant signal is the 2026 guidance cut driven by ACA subsidy expiration worsening payer mix (~$400M/quarter revenue impact), soft elective surgery volumes, and rising costs — this triggered corporate/support-function layoffs, at least one hospital divestiture, and controversial offshoring of IT/back-office roles to Hyderabad. RBC reiterated Outperform with a $435 PT on Sept 8, citing consistent H2 cadence messaging from management, which is a modest counterweight. The more concerning item is the Pomerantz securities-fraud investigation into potential misleading disclosures — early-stage and speculative, but a real overhang until it resolves. Noise to filter: retail sentiment on the India offshoring is emotional but not investable, and the Congressional trade (dependent, $1-15k, three months ago) is too small to weight. Ex-div Sept 16 ($0.78) is trivial. The binary catalyst is Q3 earnings on Oct 23 — management will need to prove the H2 cadence guide is intact.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/hca-ai-stock-forecast-2ffd9089f98e43dccf7effb2df0464be
- AI-generated; model outputs can be wrong. Not financial advice.